Ethical Issues of Gene Therapy

The world trade market for cell and gene based therapies is expected to greater than the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell based therapies are high impact disease areas with significant incurable needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases gene therapies should then not be rushed to market but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers.

 

    Related Conference of Ethical Issues of Gene Therapy

    June 20-21, 2024

    20th Global Summit on Stem Cell & Regenerative Medicine

    Dublin, Ireland
    June 27-28, 2024

    18th International Conference on Regenerative Repair and Medicine

    London, UK
    July 15-16, 2024

    7th Annual Conference on Stem Cell and Regenerative Medicine

    London, UK
    July 15-16, 2024

    7th Global Conference on Cell and Gene Therapy

    London, UK
    September 26-27, 2024

    19th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Amsterdam, Netherlands
    October 14-15, 2024

    17th World Congress on Stem Cell Research

    Paris, France
    October 23-24, 2024

    12th World Congress on Human Genetics and Genetic Diseases

    Paris, France
    November 21-22, 2024

    11th World Congress on Epigenetics and Chromosome

    Dubai, UAE
    November 21-22, 2024

    17th International Conference on Human Genomics and Genomic Medicine

    Dubai, UAE

    Ethical Issues of Gene Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in